2'-B-Methyl-Guanosine

2'-B-Methyl-Guanosine

SCHEMBL18537403

C[C@]1(O)C(O)[C@@H](CO)OC1n1cnc2c(=O)[nH]c(N)nc21

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 6/20 0.65
ADA P00813 1/20 0.57
ADORA3 P0DMS8 8/20 0.52
ADORA1 P30542 5/20 0.52
ADORA2B P29275 4/20 0.52
ALOX15 P16050 1/20 0.52
HPGD P15428 2/20 0.51
HINT1 P49773 1/20 0.49
NT5E P21589 1/20 0.47
STING1 Q86WV6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2'-B-Methyl-Guanosine SCHEMBL12758165 1.00 ADORA2A (0.65) ADORA2AADAADORA3ADORA1ADORA2B
2'-B-Methyl-Guanosine SCHEMBL12149502 1.00 ADORA2A (0.65) ADORA2AADAADORA3ADORA1ADORA2B
2'-B-Methyl-Guanosine SCHEMBL10819905 1.00 ADORA2A (0.65) ADORA2AADAADORA3ADORA1ADORA2B
2'-B-Methyl-Guanosine SCHEMBL10819882 1.00 ADORA2A (0.65) ADORA2AADAADORA3ADORA1ADORA2B
2'-B-Methyl-Guanosine SCHEMBL10208618 1.00 ADORA2A (0.65) ADORA2AADAADORA3ADORA1ADORA2B
2'-B-Methyl-Guanosine SCHEMBL474745 1.00 ADORA2A (0.65) ADORA2AADAADORA3ADORA1ADORA2B
2'-B-Methyl-Guanosine SCHEMBL15187539 1.00 ADORA2A (0.65) ADORA2AADAADORA3ADORA1ADORA2B
2'-B-Methyl-Guanosine SCHEMBL14946249 1.00 ADORA2A (0.65) ADORA2AADAADORA3ADORA1ADORA2B
2'-B-Methyl-Guanosine SCHEMBL21007207 1.00 ADORA2A (0.65) ADORA2AADAADORA3ADORA1ADORA2B
2'-B-Methyl-Guanosine SCHEMBL14842089 1.00 ADORA2A (0.65) ADORA2AADAADORA3ADORA1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1292603-B1 METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS IDENIX PHARMACEUTICALS LLC (US) 2017-02-22 EP disclosed